ZYME Q4 2022 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$402M+1925.6% YoY

Gross Profit

$350M86.9% margin

Operating Income

$319M79.4% margin

Net Income

$309M76.9% margin

EPS (Diluted)

$4.65

QoQ Revenue Growth

+15198.1%

Cash Flow

Operating Cash Flow

$318M

Free Cash Flow

$318M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$649M

Total Liabilities

$156M

Stockholders' Equity

$493M

Cash & Equivalents

$401M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$402M	$20M	+1925.6%
Gross Profit	$350M	-$35M	+1104.4%
Operating Income	$319M	-$41M	+881.9%
Net Income	$309M	-$39M	+890.3%

Revenue Segments

Upfront Fee

$18M73%

License and Service

$6M22%

Milestone Payment

$1M4%